Researchers conducted a retrospective cohort study of patients undergoing TAVR at 229 U.S. sites between November 2011 and September 2014. They used the Society of Thoracic Surgeons/American College of Cardiology TVT Registry and the CMS database.
Here are four findings:
1. Permanent pacemaker placement was required within 30 days of TAVR in 651 of the 9,785 patients (6.7 percent).
2. Age, prior conduction defect and use of self-expanding valve were positive predictors of pacemaker implantation.
3. Permanent pacemaker implantation was associated with a seven-day median hospital stay and 56.7-hour intensive care unit stay.
4. Permanent pacemaker implantation was also associated with a 24.1 percent mortality rate.
More articles on healthcare quality:
ECRI names 10 health technology hazards for 2017 — infusion errors, scope cleaning top list
HHS report identifies 7 new cancer-causing substances
AFM ruled out in death of Seattle Children’s patient, confirmed in 8 others
